Ignace Vergote's guest appearances

Ignace Vergote

IJGC Podcast

The Lancet Oncology in conversation with

Katie O'Brien

Andrew Scott

Jennifer Mueller

Sarah Ferguson

Sadie Jones

Jason Wright

Anna Collins

Julia Pugh

Scott Glaser

Benjamin Albright

Eduardo Bruera

Rebecca Fitzgerald

Takayuki Yoshino

Robert Coleman

David Kerr

OwlTail

Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers.Visit the Series hub:Gynaecological cancersContinue this conversation on social!Follow us today at...https://twitter.com/thelancet &amp; https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers. Visit the Series hub: <a href="http://www.thelancet.com/series/gynaecological-cancers" rel="nofollow" target="_blank">Gynaecological cancers</a>Continue this conversation on social! Follow us today at... <a href="https://twitter.com/thelancet" rel="nofollow" target="_blank">https://twitter.com/thelancet</a> &amp; <a href="https://www.youtube.com/redirect?event=video_description&amp;redir_token=QUFFLUhqbW5aYjBuT3dnekRNQjNxYzN1aW04dTBoRTFBUXxBQ3Jtc0tsQ2ltQUkzNWw5ZTdRRXpJaEIxN2g4TlhTWFBpak9nUVdrVG9jYVRoLW5hMXYzeVJ4dEFmZWFTeFF5TmNlTUp1VmRiWlMtbHZ6dUFyRVNJRXFrdHVCd1MxMnAyNVFDWGctTjZSV0JPV3h5WEowTTRiMA&amp;q=https%3A%2F%2FTwitter.com%2FTheLancetOncol&amp;v=IbjHE2P89WA" rel="nofollow" target="_blank">https://Twitter.com/TheLancetOncol</a> <a href="https://instagram.com/thelancetgroup" rel="nofollow" target="_blank">https://instagram.com/thelancetgroup</a> <a href="https://facebook.com/thelancetmedicaljournal" rel="nofollow" target="_blank">https://facebook.com/thelancetmedicaljournal</a> <a href="https://linkedin.com/company/the-lancet" rel="nofollow" target="_blank">https://linkedIn.com/company/the-lancet</a> <a href="https://www.youtube.com/thelancettv" rel="nofollow" target="_blank">https://youtube.com/thelancettv</a>

Ignace Vergote and Maria Kyrgiou on gynaecological cancers

In this episode of the IJGC podcast, Professor Ignace Vergote joins us for the Mentor’s Podcast. Professor Ignace Vergote is Chairman of the Department of Gynaecology and Obstetrics at the Catholic University Leuven since 2003. He published more than 900 papers on gynecologic cancer in peer-reviewed journals and his work has been cited more than 50,000 times.  He served as President of IGCS, ESGO, EORTC-GCG and ENGOT.Ignace Vergote  (@UZLeuven)

In this episode of the IJGC podcast, Professor Ignace Vergote joins us for the Mentor’s Podcast. Professor Ignace Vergote is Chairman of the Department of Gynaecology and Obstetrics at the Catholic University Leuven since 2003. He published more than 900 papers on gynecologic cancer in peer-reviewed journals and his work has been cited more than 50,000 times. He served as President of IGCS, ESGO, EORTC-GCG and ENGOT. Ignace Vergote (@UZLeuven)

The Mentors Podcast with Ignace Vergote

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Igance Vergote to talk about HIPEC in advanced ovarian cancer. Professor Ignace Vergote is Chairman of the Department of Gynaecology and Obstetrics at the Catholic University Leuven since 2003. He published more than 900 papers on gynecologic cancer in peer-reviewed journals and his work was cited more than 50.000 times.  He served as President of IGCS, ESGO, EORTC-GCG and ENGOT.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Igance Vergote to talk about HIPEC in advanced ovarian cancer. Professor Ignace Vergote is Chairman of the Department of Gynaecology and Obstetrics at the Catholic University Leuven since 2003. He published more than 900 papers on gynecologic cancer in peer-reviewed journals and his work was cited more than 50.000 times. He served as President of IGCS, ESGO, EORTC-GCG and ENGOT.